Literature DB >> 19287153

Copy number alterations and copy number variation in cancer: close encounters of the bad kind.

F Speleman1, C Kumps, K Buysse, B Poppe, B Menten, K De Preter.   

Abstract

Recent studies have unveiled copy number variants (CNVs) as an important source of genetic variation. Many of these CNVs contain coding sequences, which have been shown to be dosage sensitive. Evidence is accumulating that certain CNVs have impact on susceptibility to human diseases such as HIV infection and autoimmune diseases, as well as on adaptability to environmental conditions or nutrition. The possible role and impact of CNVs on cancer development and progression is only now emerging. In this review we look into the role of CNVs and their associated genomic structural features in relation to the formation of chromosome alterations in cancer cells and evolutionary genomic plasticity, as well as the de novo occurrence of known or putative CNVs as somatic events during oncogenesis. The role of germline CNVs in cancer predisposition is still largely unexplored. A number of observations seem to warrant the importance of further studies to elucidate the impact of these variants in the early steps of carcinogenesis. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19287153     DOI: 10.1159/000184706

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  21 in total

1.  Coexistence of copy number increases of ZNF217 and CYP24A1 in colorectal cancers in a Chinese population.

Authors:  Zhengyu Fang; Yi Xiong; Chao Zhang; Jiana Li; Li Liu; Manhui Li; Wei Zhang; Jun Wan
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

2.  Ultradense array CGH and discovery of micro-copy number alterations and gene fusions in the cancer genome.

Authors:  Ewa Przybytkowski; Adriana Aguilar-Mahecha; Sheida Nabavi; Peter J Tonellato; Mark Basik
Journal:  Methods Mol Biol       Date:  2013

3.  SERPINA5 inhibits tumor cell migration by modulating the fibronectin-integrin β1 signaling pathway in hepatocellular carcinoma.

Authors:  Ying Jing; Deshui Jia; Chun-Ming Wong; Irene Oi-Lin Ng; Zhenfeng Zhang; Li Liu; Qifeng Wang; Fangyu Zhao; Jinjun Li; Ming Yao; Xingzhong Wu; Xianghuo He
Journal:  Mol Oncol       Date:  2013-12-18       Impact factor: 6.603

4.  The relationship between EGFR gain and VHL loss in lung adenocarcinoma and poor patient survival.

Authors:  Yushi Zhao; Ye Li; Shengfa Wang; Hongguang Lu; Jianxin Chen; Zhijie Zhang; Yubin Jin; Zhong-Zheng Zhu
Journal:  Int J Clin Oncol       Date:  2011-05-11       Impact factor: 3.402

Review 5.  The Architecture of a Precision Oncology Platform.

Authors:  Alessandro Laganà
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

6.  Identification of Copy Number Alterations from Next-Generation Sequencing Data.

Authors:  Sheida Nabavi; Fatima Zare
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

7.  MixHMM: inferring copy number variation and allelic imbalance using SNP arrays and tumor samples mixed with stromal cells.

Authors:  Zongzhi Liu; Ao Li; Vincent Schulz; Min Chen; David Tuck
Journal:  PLoS One       Date:  2010-06-01       Impact factor: 3.240

8.  Inferring haplotypes of copy number variations from high-throughput data with uncertainty.

Authors:  Mamoru Kato; Seungtai Yoon; Naoya Hosono; Anthony Leotta; Jonathan Sebat; Tatsuhiko Tsunoda; Michael Q Zhang
Journal:  G3 (Bethesda)       Date:  2011-06-01       Impact factor: 3.154

9.  A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations.

Authors:  Tao Xie; Giovanni D' Ario; John R Lamb; Eric Martin; Kai Wang; Sabine Tejpar; Mauro Delorenzi; Fred T Bosman; Arnaud D Roth; Pu Yan; Stephanie Bougel; Antonio Fabio Di Narzo; Vlad Popovici; Eva Budinská; Mao Mao; Scott L Weinrich; Paul A Rejto; J Graeme Hodgson
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

10.  Copy-number variation of cancer-gene orthologs is sufficient to induce cancer-like symptoms in Saccharomyces cerevisiae.

Authors:  Michaela de Clare; Stephen G Oliver
Journal:  BMC Biol       Date:  2013-03-25       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.